paclitaxel has been researched along with Hematologic Malignancies in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Kim, D; Kim, M; Kim, R; Kim, S; Kim, Y; Koh, Y; Ku, J; Kwon, NH; Lee, K; Lee, N; Song, S; Yoon, SS | 1 |
Hu, WH; Jin, T; Li, PJ; Luo, DH; Mo, HY | 1 |
Choi, M; Gadgeel, SM; Heilbrun, LK; Jiang, PQ; Smith, DW | 1 |
De Arriba, F; Fernández, A; Heras, I; Lozano, ML; Rivera, J; Vicente, V | 1 |
Adamo, L; Conticello, C; De Maria, R; Giannone, I; Gulisano, M; Musumeci, T; Pignatello, R; Puglisi, G; Vicari, L | 1 |
Bane, FT; Bannon, JH; Campaini, G; Campiani, G; Mc Gee, MM; Pennington, SR; Williams, DC; Zisterer, DM | 1 |
Burzynski, J; Callander, N; Freytes, C; Greene, R; McKibbin, T; Ochoa-Bayona, J; Tsai, TW | 1 |
7 other study(ies) available for paclitaxel and Hematologic Malignancies
Article | Year |
---|---|
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alternative Splicing; Cell Line, Tumor; Drug Resistance, Neoplasm; Exons; Female; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Image Processing, Computer-Assisted; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Nuclear Proteins; Paclitaxel; Prognosis; Single-Cell Analysis; Young Adult | 2020 |
The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Hematologic Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome | 2018 |
Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Neoplasms; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thoracic Neoplasms; Treatment Outcome; Urogenital Neoplasms | 2008 |
Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cell Movement; Female; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Paclitaxel; Salvage Therapy | 2008 |
Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Colloids; Coumarins; Drug Carriers; Hematologic Neoplasms; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Neoplasms; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2008 |
The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1,
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Division; Cell Membrane; Cell Nucleus; Cyclophilin A; Cytoplasm; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; G2 Phase; Hematologic Neoplasms; Humans; Hydrolysis; Microtubules; Monocytes; NIMA-Interacting Peptidylprolyl Isomerase; Oxazepines; Paclitaxel; Peptide Mapping; Peptidylprolyl Isomerase; Pyrroles; Silver Staining; Trypsin | 2009 |
Paclitaxel and filgrastim for hematopoietic progenitor cell mobilization in patients with hematologic malignancies after failure of a prior mobilization regimen.
Topics: Aged; Antigens, CD34; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Middle Aged; Paclitaxel; Recombinant Proteins; Transplantation, Autologous; Treatment Failure | 2007 |